Key points are not available for this paper at this time.
Protocol for second-line CCB BP effects; leaves open current evidence synthesis for hypertension add-on therapy.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary objective: To quantify the additional reduction in systolic blood pressure (SBP) and diastolic blood pressure (DBP) of calcium‐channel blocker (CCB) therapy as a second‐line drug in hypertensive patients. Secondary objectives: 1. To determine the effects of second‐line CCB on variability of blood pressure. 2. To determine the effects of second‐line CCB on pulse pressure. 3. To quantify the effect of second‐line CCB on heart rate. 4. To quantify the effect of second‐line CCB on withdrawals due to adverse effects.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: